| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.1 | $0-$5k | 0.00 |
Summary
A vulnerability was found in ExpressionEngine 1.2.1. It has been declared as problematic. This affects an unknown function of the file index.php. Such manipulation leads to cross site scripting. This vulnerability is documented as CVE-2008-0201. The attack can be executed remotely. Additionally, an exploit exists.
Details
A vulnerability, which was classified as problematic, has been found in ExpressionEngine 1.2.1. Affected by this issue is some unknown processing of the file index.php. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in index.php in ExpressionEngine 1.2.1 and earlier allows remote attackers to inject arbitrary web script or HTML via the URL parameter.
The weakness was released 01/09/2008 by MustLive (Website). The advisory is available at securityfocus.com. This vulnerability is handled as CVE-2008-0201 since 01/09/2008. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. Technical details as well as a public exploit are known. This vulnerability is assigned to T1059.007 by the MITRE ATT&CK project.
The exploit is available at securityfocus.com. It is declared as highly functional. By approaching the search of inurl:index.php it is possible to find vulnerable targets with Google Hacking.
The vulnerability is also documented in the databases at X-Force (39442) and SecurityFocus (BID 27128†). Entries connected to this vulnerability are available at VDB-40472, VDB-40471, VDB-40470 and VDB-40469. If you want to get best quality of vulnerability data, you may have to visit VulDB.
Product
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Highly functional
Download: 🔍
Google Hack: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
01/03/2008 🔍01/09/2008 🔍
01/09/2008 🔍
01/09/2008 🔍
03/16/2015 🔍
09/14/2018 🔍
Sources
Advisory: securityfocus.com⛔Researcher: MustLive
Status: Confirmed
CVE: CVE-2008-0201 (🔍)
GCVE (CVE): GCVE-0-2008-0201
GCVE (VulDB): GCVE-100-40466
X-Force: 39442 - ExpressionEngine index.php cross-site scripting
SecurityFocus: 27128 - ExpressionEngine HTTP Response Splitting and Cross Site Scripting Vulnerabilities
scip Labs: https://www.scip.ch/en/?labs.20161013
See also: 🔍
Entry
Created: 03/16/2015 13:43Updated: 09/14/2018 08:17
Changes: 03/16/2015 13:43 (56), 09/14/2018 08:17 (1)
Complete: 🔍
Cache ID: 216::103
If you want to get best quality of vulnerability data, you may have to visit VulDB.
No comments yet. Languages: en.
Please log in to comment.